REPORT ID 3045

United States Lancets Market Report 2017

Publish Date
12-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the United States Lancets market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Lancets in these regions, from 2012 to 2022 (forecast).

United States Lancets market competition by top manufacturers/players, with Lancets sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    Lifescan
    BD
    Bayer
    Abbott
    B. Braun
    ARKRAY
    Terumo
    I-SENS
    Nipro
    Omron
    Infopia
    AgaMatrix
    Smiths Medical
    Sarstedt
    SANNUO
    Yicheng
    Yuwell
    Greiner Bio One

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Safety Lancets
    Homecare Lancets
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Lancets for each application, including
    Cholesterol Tests
    Glucose Tests
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Lancets Market Report 2017
1 Lancets Overview
    1.1 Product Overview and Scope of Lancets
    1.2 Classification of Lancets by Product Category
        1.2.1 United States Lancets Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Lancets Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Safety Lancets
        1.2.4 Homecare Lancets
    1.3 United States Lancets Market by Application/End Users
        1.3.1 United States Lancets Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Cholesterol Tests
        1.3.3 Glucose Tests
        1.3.4 Others
    1.4 United States Lancets Market by Region
        1.4.1 United States Lancets Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Lancets Status and Prospect (2012-2022)
        1.4.3 Southwest Lancets Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Lancets Status and Prospect (2012-2022)
        1.4.5 New England Lancets Status and Prospect (2012-2022)
        1.4.6 The South Lancets Status and Prospect (2012-2022)
        1.4.7 The Midwest Lancets Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Lancets (2012-2022)
        1.5.1 United States Lancets Sales and Growth Rate (2012-2022)
        1.5.2 United States Lancets Revenue and Growth Rate (2012-2022)

2 United States Lancets Market Competition by Players/Suppliers
    2.1 United States Lancets Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Lancets Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Lancets Average Price by Players/Suppliers (2012-2017)
    2.4 United States Lancets Market Competitive Situation and Trends
        2.4.1 United States Lancets Market Concentration Rate
        2.4.2 United States Lancets Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Lancets Manufacturing Base Distribution, Sales Area, Product Type

3 United States Lancets Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Lancets Sales and Market Share by Region (2012-2017)
    3.2 United States Lancets Revenue and Market Share by Region (2012-2017)
    3.3 United States Lancets Price by Region (2012-2017)

4 United States Lancets Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Lancets Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Lancets Revenue and Market Share by Type (2012-2017)
    4.3 United States Lancets Price by Type (2012-2017)
    4.4 United States Lancets Sales Growth Rate by Type (2012-2017)

5 United States Lancets Sales (Volume) by Application (2012-2017)
    5.1 United States Lancets Sales and Market Share by Application (2012-2017)
    5.2 United States Lancets Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Lancets Players/Suppliers Profiles and Sales Data
    6.1 Roche
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Lancets Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Lifescan
        6.2.2 Lancets Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 BD
        6.3.2 Lancets Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bayer
        6.4.2 Lancets Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bayer Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Abbott
        6.5.2 Lancets Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 B. Braun
        6.6.2 Lancets Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 ARKRAY
        6.7.2 Lancets Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 ARKRAY Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Terumo
        6.8.2 Lancets Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 I-SENS
        6.9.2 Lancets Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Nipro
        6.10.2 Lancets Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Omron
    6.12 Infopia
    6.13 AgaMatrix
    6.14 Smiths Medical
    6.15 Sarstedt
    6.16 SANNUO
    6.17 Yicheng
    6.18 Yuwell
    6.19 Greiner Bio One

7 Lancets Manufacturing Cost Analysis
    7.1 Lancets Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Lancets

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Lancets Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Lancets Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Lancets Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Lancets Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Lancets Sales Volume Forecast by Type (2017-2022)
    11.3 United States Lancets Sales Volume Forecast by Application (2017-2022)
    11.4 United States Lancets Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer